There is a tendency to view the development of antimalarial-drug resistance as an inevitable outcome of the drugs' widespread use. Yet resistance has been accelerated by the way the drugs are used and by the social and economic conditions in which they are used.
No takes yet. Share an insight, caveat, or question.
Randall M. Packard (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: